All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
ZBH / Zimmer Biomet Holdings, Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc.
|
|
|
|
|
|
|
|
US7438151026 / Providence Service Corp. (The)
|
|
|
|
|
|
|
|
URGN / UroGen Pharma Ltd.
|
|
|
|
|
|
|
|
NVRO / Nevro Corp.
|
|
|
|
|
|
|
|
ENTA / Enanta Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
BMRN / BioMarin Pharmaceutical Inc.
|
|
|
|
|
|
|
|
GTS / Triple-S Management Corp
|
|
|
|
|
|
|
|
WCG / Wellcare Health Plans, Inc.
|
|
|
|
|
|
|
|
OPTN / OptiNose, Inc.
|
|
|
|
|
|
|
|
NVRO / Nevro Corp. Call
|
|
|
|
|
|
|
|
WAGE / WageWorks Inc.
|
|
|
|
|
|
|
|
CI / The Cigna Group
|
|
|
|
|
|
|
|
CBIO / Crescent Biopharma, Inc.
|
|
|
|
|
|
|
|
IL0011177958 / Intec Pharma Ltd
|
|
|
|
|
|
|
|
HNGR / Hanger Inc
|
|
|
|
|
|
|
|
ACIU / AC Immune SA
|
|
|
|
|
|
|
|
LGND / Ligand Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
ASGN / ASGN Incorporated
|
|
|
|
|
|
|
|
018490100 / Allergan plc
|
|
|
|
|
|
|
|
MTEM / Molecular Templates, Inc.
|
|
|
|
|
|
|
|
SBBP / Strongbridge Biopharma plc
|
|
|
|
|
|
|
|
RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
AXGN / Axogen, Inc.
|
|
|
|
|
|
|
|
EXAS / Exact Sciences Corporation Put
|
|
|
|
|
|
|
|
UROV / Urovant Sciences Ltd
|
|
|
|
|
|
|
|
NLTX / Neoleukin Therapeutics, Inc.
|
|
|
|
|
|
|
|
CDTX / Cidara Therapeutics, Inc.
|
|
|
|
|
|
|
|
BMY / Bristol-Myers Squibb Company
|
|
|
|
|
|
|
|
TPST / Tempest Therapeutics, Inc.
|
|
|
|
|
|
|
|
ASMB / Assembly Biosciences, Inc.
|
|
|
|
|
|
|
|
AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
TLGT / Teligent Inc
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
PIRS / Pieris Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
EOLS / Evolus, Inc.
|
|
|
|
|
|
|
|
IOVA / Iovance Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
MGTX / MeiraGTx Holdings plc
|
|
|
|
|
|
|
|
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
CNC / Centene Corporation
|
|
|
|
|
|
|
|
ALBO / Albireo Pharma Inc
|
|
|
|
|
|
|
|
MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
ALDX / Aldeyra Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
VKTX / Viking Therapeutics, Inc.
|
|
|
|
|
|
|
|
KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|